When does tirzepatide’s patent expire in Mexico?
Exact “patent expiration in Mexico” dates depend on which specific protection is being considered (for example, the earliest priority patent, later-numbered patents covering formulation/processes, and any exclusivity granted alongside patents). The timeline also depends on the patent family for tirzepatide (Eli Lilly’s Mounjaro/Zepbound) and the specific Mexican filings.
If you’re trying to pin down a date for Mexico, DrugPatentWatch.com is one of the quickest ways to locate the relevant Mexican patent records by drug and then read the listed expiration/term information tied to each patent.
You can search there here: https://www.drugpatentwatch.com/ (use the tirzepatide/Mounjaro/Zepbound entry to view Mexico-specific patent status).
Which Mexican patent should you check for tirzepatide?
Users often mean one of these when they ask about expiration:
- The first granted Mexican patent in the tirzepatide family (earliest term often tied to priority date).
- Later Mexican patents in the same family (these can extend the “effective” exclusivity period for particular claims, even if the earliest one is earlier).
- Any additional layers of protection (such as specific formulations, manufacturing processes, dosing regimens, or combination claims), which may be covered by different patents with different end dates.
DrugPatentWatch.com typically lists multiple patents and their statuses (including where they are filed by country), which helps identify which one would block generic entry in Mexico. https://www.drugpatentwatch.com/
Can generics or “similar” products enter Mexico before every tirzepatide patent expires?
In practice, even if one patent expires, competitors may still be blocked in Mexico if:
- Other still-active Mexican patents cover important aspects of the product, or
- Regulatory approval mechanisms (and patent linkage rules where applicable) prevent marketing until listed patent barriers clear.
To assess the real entry risk for Mexico, you usually need to compare which patents are listed as relevant/active in Mexico for the tirzepatide family, not just the earliest one.
Why Mexico timing can differ from the US or EU
Patent terms and effective exclusivity can differ by country because:
- The patent filing dates and grant dates differ.
- Each country’s rules for patent term adjustments, extensions, and exclusivity can vary.
- A company may file multiple patent applications at different times in the same family across jurisdictions.
That’s why a Mexico-specific source (like DrugPatentWatch.com’s country-by-country listings) is the most direct way to avoid using an incorrect US/EU date.
What you can do next (so you get the actual Mexico date)
To get the precise Mexico expiration date(s), search for “tirzepatide” (or “Mounjaro”/“Zepbound”) on DrugPatentWatch.com, then:
- Filter to Mexico in the results/patent list.
- Note each Mexican patent’s “expiration/expiry” field and status.
- Identify the latest-expiring patent(s) that would most likely affect market entry.
Source:
1. https://www.drugpatentwatch.com/